-
Mashup Score: 1Newsletter — NephJC - 10 month(s) ago
We send an e-mail once-a-week with a breakdown and summary of every article we discuss at #NephJC. If you are interested in getting this e-mail, sign up here.We promise to:Respect your privacyNever sell your e-maill addressNever send more than one e-mail a week
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 1Merchandise — NephJC - 10 month(s) ago
NephJC is a not-for-profit organization and recognized by the US IRS as a 503c. All money raised is spent on the #NephTwitter community. NephJC is governed by a 5 member board of directors. Joel Topf, presidentSwapnil Hiremath, vice presidentMatt Sparks, treasurerAnna BurgnerMichelle Rheault, secretaryFunds are used to support the The Kidney Week and KIDNEYcon Tweet-ups. Money is used to help…
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 0NephJC 2023 Pledge Drive — NephJC - 10 month(s) ago
Help keep NephJC a vital, original, and unbiased source of medical education.
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 4
The next #Nephtrials discussion will feature a deep dive into convection/hemodiafiltration, and the ongoing registry based trial, H4RT
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 10HDF vs HD: Need for CONVINCE-ing Evidence — NephJC - 10 month(s) ago
This week, we will discuss CONVINCE, a randomized controlled trial, about the long-lasting battle between hemodialysis and hemodiafiltration. Will it convince the unconvinced, or will it diffuse even more uncertainty into community?
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 11The CONVINCE Visual Abstract — NephJC - 10 month(s) ago
Welcome to #TenTweetNephJC for a short recap! Nephrologists warned of renalism neglecting cardiac ischemia in kidne… https://t.co/rkjHTRF3t7 Apr 5, 2023, 5:36 AM Ongoing IgAN trials https://t.co/24KdgAWAEb Mar 29, 2023, 1:10 PM Looking forward…
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 23HDF vs HD: Need for CONVINCE-ing Evidence — NephJC - 10 month(s) ago
This week, we will discuss CONVINCE, a randomized controlled trial, about the long-lasting battle between hemodialysis and hemodiafiltration. Will it convince the unconvinced, or will it diffuse even more uncertainty into community?
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 5NephJC 2023 Pledge Drive — NephJC - 10 month(s) ago
Help keep NephJC a vital, original, and unbiased source of medical education.
Source: NephJCCategories: Latest Headlines, NephrologyTweet
-
Mashup Score: 6GAD ain't BAD — NephJC - 10 month(s) ago
In early 2000s there was an epidemic….and then it died down. Have we successfully eliminated the scourge of NSF by appropriately changing our behaviour? Perhaps the pendulum has swung too much and needs to come back to the middle.
Source: NephJCCategories: Critical Care, Latest HeadlinesTweet
-
Mashup Score: 6Freely Filtered 059: Furosemide v Torsemide — NephJC - 10 month(s) ago
Freely Filtered 059: Another dogma shredding trial about diuretics, this time torsemide goes up against king furosemide and its ability to prevent rehospitalization CV events.
Source: NephJCCategories: Cardiologists, Latest HeadlinesTweet
If you haven’t, please sign up for our weekly newsletter https://t.co/Sm1AmzpSld #NephJC